Molecular Test Listing

Molecular Requisition


NEUROLOGICAL PANEL:

The largest grouping of common disorders with ataxia include Huntington disease (HD), Dentatorubral-Pallidoluysian Atrophy (DRPLA), Friedreich ataxia (FRDA) and the Spinocerebellar Ataxias (SCAs). With the exception of FRDA (recessive), these disorders are autosomal dominant neurodegenerative disorders (see individual test listing for fuller descriptions). They are typically adult onset disorders but severe cases can be expressed in childhood.  Each disorder has differences in clinical symptoms but the differences are often subtle and the generally overlap. 

In order to most efficiently and economically deal with the problems in diagnosis the Ataxia Neurological Panel combines the individual tests for HD, DRPLA, FRDA and  SCA 1, 2, 3, 6, and 7 into a panel that can be ordered as a separate test. All the disorders incorporated into the panel belong to a class of trinucleotide repeat conditions in which there is an unstable expansion of the repeat in the gene.

 

REASONS FOR REFERRAL:

  • Individuals with ataxia or other neurological motor symptoms.
  • To discriminate between conditions with overlapping clinical symptoms in an affected individual.
  • Individuals at risk who wish prenatal diagnosis.

TESTING METHODOLOGY:

  • Fluorescent PCR sizing of the trinucleotide repeat region of the gene.

SPECIMEN REQUIREMENTS:

  • Blood EDTA (purple top) tubes:  

            Newborn: minimum 1-2 mL          

            Child/Adult: prefer 2 tubes of 3-5 mL

  • Prenatal testing: Please contact the laboratory for instructions.
  • A Molecular Genetics Laboratory Test Requisition must accompany the specimen. Contact the Molecular Laboratory at 918-502-1721 to obtain further information.

  • TURNAROUND TIME:     15 working days

    CPT CODES:    

    (SCA1 performed on an investigational basis only)